Insider · CIK 0001873879

FitzPatrick Margaret M

Reports to the SEC for 2 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001873879

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	ANTXAN2 Therapeutics, Inc.P Purchase	Director	PPurchase	+2,098 sh	$5.53	+$11.6K	10,708
2026-03-19	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,463
2026-03-19	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2026-03-19	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,362
2026-03-19	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.4K sh	—	—	0
2026-03-19	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.7K sh	—	—	23,742
2026-03-19	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.7K sh	—	—	0
2026-02-20	ANTXAN2 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.4K sh	—	—	20,400
2025-09-09	VTGNVistagen Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.6K sh	—	—	17,600
2025-05-28	ANTXAN2 Therapeutics, Inc.P Purchase	Director	PPurchase	+8,610 sh	$1.18	+$10.1K	8,610
2025-05-22	ANTXAN2 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.1K sh	—	—	19,111
2024-09-06	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2024-06-19	ANTXAN2 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+64.5K sh	—	—	64,503
2024-03-04	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-07	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.7K sh	—	—	23,742
2022-05-12	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,362
2022-05-05	ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,463
2022-03-01	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2021-07-21	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
Sep 24
FitzPatrick Margaret M0001193125-26-380595
SEC(opens sec.gov)
Mar 234
FitzPatrick Margaret M0001193125-26-120221
SEC(opens sec.gov)
Feb 234
FitzPatrick Margaret M0001193125-26-064028
SEC(opens sec.gov)
Sep 114
FitzPatrick Margaret M0001411685-25-000076
SEC(opens sec.gov)
May 294
FitzPatrick Margaret M0000950170-25-078982
SEC(opens sec.gov)
May 234
FitzPatrick Margaret M0000950170-25-077062
SEC(opens sec.gov)
Sep 104
FitzPatrick Margaret M0001415889-24-023145
SEC(opens sec.gov)
Jun 214
FitzPatrick Margaret M0000950170-24-076406
SEC(opens sec.gov)
Mar 64
FitzPatrick Margaret M0001415889-24-007097
SEC(opens sec.gov)
Jun 94
FitzPatrick Margaret M0000899243-23-015320
SEC(opens sec.gov)
May 164
FitzPatrick Margaret M0000899243-22-018286
SEC(opens sec.gov)
May 94
FitzPatrick Margaret M0000899243-22-017371
SEC(opens sec.gov)
Mar 34
FitzPatrick Margaret M0001415889-22-002291
SEC(opens sec.gov)
Jul 224
FitzPatrick Margaret M0001415889-21-003674
SEC(opens sec.gov)

Companies

Address

C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100

MENLO PARK, CA, 94025